ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 419161 | Rec_0431819 | E10-Ctn[15-34] |
EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
Escherichia coli KPC+ 001812446 |
>128 μg/mL | MBC |
30042491 | - |
YES |
| 419162 | Rec_0431820 | E10-Ctn[15-34] |
EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
Klebsiella pneumoniae ATCC 13883 |
>128 μg/mL | MBC |
30042491 | - |
YES |
| 419163 | Rec_0431821 | E10-Ctn[15-34] |
EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
Klebsiella pneumoniae KPC+ 001825971 |
>128 μg/mL | MBC |
30042491 | - |
YES |
| 419164 | Rec_0431822 | E10-Ctn[15-34] |
EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
Staphylococcus aureus ATCC 25923 |
>128 μg/mL | MBC |
30042491 | - |
YES |
| 419165 | Rec_0431823 | E10-Ctn[15-34] |
EEEEEEEEEEKKRLKKIFKKPMVIGVTIPF |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer, Cytotoxic |
Galleria mellonella |
- | In vivo toxicity/survival assay |
30042491 | - |
YES |
| 419166 | Rec_0431824 | Apratoxin A |
XXPXXX |
Lyngbya majuscula [Bacterium] |
Anticancer, In vivo antitumor activity |
mice bearing subcutaneous colon adenocarcinoma |
31 % T/C | in vivo antitumor assay |
11389621 | - |
YES |
| 419167 | Rec_0431825 | Huwentoxin-V mutant, mHuwentoxin-V |
ECRWYLGGCSQDGDCCKHLQCHSNYEWCVWDGT |
Selenocosmia huwena [Animal] |
Toxin, Experimentally inactive mutant |
mice |
- | in vivo toxicity assay (intraperitoneal/intracerebroventricular administration) |
12893056 | - |
YES |
| 419168 | Rec_0431826 | Huwentoxin-V mutant, mHuwentoxin-V |
ECRWYLGGCSQDGDCCKHLQCHSNYEWCVWDGT |
Selenocosmia huwena [Animal] |
Toxin, Experimentally inactive mutant |
isolated mouse phrenic nerve-diaphragm preparation |
- | neuromuscular transmission assay |
12893056 | - |
YES |
| 419169 | Rec_0431827 | L5a cell-penetrating peptide |
RRWQW |
synthetic construct [Synthetic] |
Cell-penetrating, DNA delivery |
A549 human lung cancer cells |
- | cellular uptake/transfection assay |
26942714 | - |
YES |
| 419170 | Rec_0431828 | omega-Conotoxin MVIID |
CQGRGASCRKTMYNCCSGSCNRGRC |
Conus magus [Animal] |
Toxin, Calcium channel blocker, Q-type calcium-channel inhibitor |
bovine adrenal chromaffin cells |
70 % | K+-evoked 45Ca2+ uptake inhibition assay |
9359903 | - |
YES |
| 419171 | Rec_0431829 | omega-Conotoxin MVIID |
CQGRGASCRKTMYNCCSGSCNRGRC |
Conus magus [Animal] |
Toxin, Calcium channel blocker, Q-type calcium-channel inhibitor |
bovine adrenal chromaffin cells |
70 % | K+-evoked catecholamine secretion inhibition assay |
9359903 | - |
YES |
| 419172 | Rec_0431830 | AMP-016 |
GLWDVIKKVASVIGGL |
synthetic construct [Synthetic] |
Cytotoxicity |
HEK-293 human embryonic kidney cells |
>32 μg/mL | IC50 (cytotoxicity assay) |
31336137 | - |
YES |
| 419173 | Rec_0431831 | Interferon-induced transmembrane protein 2 |
MSHNSQAFLSTNAGLPPSYETIKEEYGVTELGEPSNSAVVRTTVINMPREVSVPDHVVWSLFNTLFFNACCLGFVAYAYSVKSRDRKMVGDVVGAQAYASTAKCLNISSLIFSILMVIICIIIFSTTSVVVFQSFAQRTPHSGF |
Mus musculus [Animal] |
Antiviral, Replication inhibitor, Anti-EBOV |
Ebola virus (EBOV); Vero E6 cells; A549 cells |
- | infectious virus replication assay (viral titer by quantitative RT-PCR) |
21253575 | - |
YES |
| 419174 | Rec_0431832 | Interferon-induced transmembrane protein 2 |
MSHNSQAFLSTNAGLPPSYETIKEEYGVTELGEPSNSAVVRTTVINMPREVSVPDHVVWSLFNTLFFNACCLGFVAYAYSVKSRDRKMVGDVVGAQAYASTAKCLNISSLIFSILMVIICIIIFSTTSVVVFQSFAQRTPHSGF |
Mus musculus [Animal] |
Antiviral, Replication inhibitor, Anti-SARS-CoV |
SARS-CoV; Vero cells |
- | infectious virus replication assay (plaque assay) |
21253575 | - |
YES |
| 419175 | Rec_0431833 | S. amritsarensis lipopeptide |
ATQSHQ |
Streptomyces amritsarensis [Bacterium] |
Cytotoxicity tested, Non-cytotoxic |
Chinese hamster ovary (CHO) cells |
- | cytotoxicity assay |
25006539 | - |
YES |
| 419176 | Rec_0431834 | β-casein(177-183) antithrombotic peptide |
AVPYPQR |
Bos grunniens [Animal] |
Antithrombotic, Fibrinolytic |
Fibrin |
- | agarose-fibrin plate activity assay |
- | CN103388015A |
YES |
| 419177 | Rec_0431835 | beta-casein(177-183) AVPYPQR |
AVPYPQR |
Bos taurus [Animal] |
Cytotoxicity evaluation |
Human umbilical vein endothelial cells (HUVECs) |
- | cell viability assay |
- | - |
YES |
| 419178 | Rec_0431836 | beta-casein(177-183) AVPYPQR |
AVPYPQR |
Bos taurus [Animal] |
Transglutaminase substrate, Enzyme substrate |
Streptomyces mobaraensis transglutaminase (SMTG); Streptomyces cinnamoneus transglutaminase (SCTG) |
- | LC-MS cross-linking substrate assay with L-lysine |
31766946 | - |
YES |
| 419179 | Rec_0431837 | SEQ ID NO 5 antimicrobial peptide |
RVLRQWPIGRVLRRVLRRVLR |
synthetic construct [Synthetic] |
Antimicrobial; Antibacterial |
Bacillus subtilis ATCC 62037 |
1 μg/mL | MIC |
- | US 2005/0215481 A1 |
YES |
| 419180 | Rec_0431838 | SEQ ID NO 5 antimicrobial peptide |
RVLRQWPIGRVLRRVLRRVLR |
synthetic construct [Synthetic] |
Antimicrobial; Antibacterial |
Staphylococcus aureus ATCC 15752 |
1 μg/mL | MIC |
- | US 2005/0215481 A1 |
YES |